The Swedish nationwide experience of converting transplant patients treated with Sandimmun to the New Galenic formulation Sandimmun-Neoral

Transplantation Proceedings

Volumn 29, Issue 1-2, 1997, Pages 280-283

  Wilczek, H E ^a   Berglin, E ^b   Blohme I ^b   Backman L ^b   Fehrman, I ^b   Kallen R ^b   Nyberg, G ^b   Sawe J ^b   Wahlberg, J ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN A;

CONFERENCE PAPER; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG FORMULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SWEDEN;

ADMINISTRATION, ORAL; CYCLOSPORINE; DOSAGE FORMS; HEART TRANSPLANTATION; HEART-LUNG TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; PANCREAS TRANSPLANTATION; SWEDEN;

EID: 0031002558     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(96)00093-0     Document Type: Conference Paper

References (8)

1. Kovarik JM, Mueller EA, Niese D: Ther Drug Monit 18:429, 1996
2. Kovarik JM, Mueller EA, van Bree JB, et al: Transplantation 58(6):658, 1994
3. Mueller EA, Kovarik JM, van Bree JB, et al: Pharm Res 10:S315, 1993
4. Wahlberg J, Wilczek HE, Fauchald P, et al: Transplantation 60(7):648, 1995
5. Mueller EA, Kovarik JM, van Bree, et al: Transplantation 57:1178, 1994
6. Mueller EA, Kallay Z, Kovarik JM, et al: Transplant Proc 27(1):834, 1995
7. Taesch S, Niese D: Transpl Int 7:S263, 1994
8. Kovarik JM, Kallay Z, Mueller EA, et al: Transpl Int 8:335, 1995